APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
08/18/2026
Back to search
Official data from USPTO
PSOMAGEN
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
PSOMAGEN
ST13
US500000088428027Class
42, 44
Filing
88428027
Registration
6397178
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
39
Latest update
08/18/2026
Trademark type
Word
Nice classes
42, 44
Filing date
05/13/2019
Registration date
06/22/2021
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/22/2021
Last transaction
08/18/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use, Foreign priority
First use anywhere
08/02/2019
First use in commerce
10/25/2019
Drawing code
4
Owner type
03
Owner location
ROCKVILLE, MD, US
Examiner
HOWARD, PARKER WALDRIP
Law office
M80
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
PSOMAGEN, INC.
Macrogen Corp.
Representatives
Sang K. Park Psomagen, Inc.
Technical classification
Nice Classes
Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 42
DNA testing for scientific research purposes; DNA sequencing analysis for scientific research purposes; research and development of DNA chips; scientific research in the nature of structural and functional analysis of genomes; multiple nucleotide sequence analysis for scientific research purposes; providing information relating to scientific analysis of the genetic information via online networks; testinginspectionresearch or development of pharmaceutical preparations for gene therapyconducting clinical trials for others; biological information checkgenetic testing for scientific research purposes; biological information checkgenetic testing for medical research purposes; research in the field of gene analysis
Class 44
Genetic testing for medical and therapeutic purposes; provision of genetic information for medical and therapeutic purposes; DNA screening for medical purposes; genetic counseling for medical purposes; analysis of acid for medical diagnosis purposes
Publications
History of USPTO decisions and trademark events.
39 publications found
ES8R
TEAS SECTION 8 RECEIVED
06/23/2026
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
06/22/2026
R.PR
REGISTERED-PRINCIPAL REGISTER
06/22/2021
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
05/21/2021
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
05/20/2021
SUPC
STATEMENT OF USE PROCESSING COMPLETE
05/04/2021
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
05/04/2021
IUAF
USE AMENDMENT FILED
04/20/2021
EISU
TEAS STATEMENT OF USE RECEIVED
04/20/2021
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
04/20/2021
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
02/23/2021
PUBO
PUBLISHED FOR OPPOSITION
02/23/2021
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02/03/2021
FIXD
ELECTRONIC RECORD REVIEW COMPLETE
01/19/2021
ERRR
ON HOLD - ELECTRONIC RECORD REVIEW REQUIRED
01/15/2021
ALIE
ASSIGNED TO LIE
01/11/2021
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
01/11/2021
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/04/2021
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/04/2021
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
01/04/2021
RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
07/28/2020
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
01/03/2020
GNSL
LETTER OF SUSPENSION E-MAILED
01/03/2020
CNSL
SUSPENSION LETTER WRITTEN
01/03/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
12/11/2019
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
12/11/2019
ALIE
ASSIGNED TO LIE
12/04/2019
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
11/22/2019
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
11/22/2019
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/11/2019
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/11/2019
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
08/02/2019
GNRT
NON-FINAL ACTION E-MAILED
08/02/2019
CNRT
NON-FINAL ACTION WRITTEN
08/02/2019
DOCK
ASSIGNED TO EXAMINER
07/29/2019
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
06/19/2019
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
05/29/2019
NWAP
NEW APPLICATION ENTERED
05/16/2019
Continuous trademark protection
Get notified about every new filing that threatens PSOMAGEN or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.